What is an intradiscal regenerative injection?
The discs between the vertebrae provide cushioning and help the spine move normally. Over time, a disc can become dehydrated, damaged, or degenerative, potentially contributing to chronic neck or low back pain.
An intradiscal injection targets the disc itself. Using advanced imaging guidance, Dr. Shamloo precisely accesses the affected disc and delivers the selected regenerative therapy directly into it.
Why treat the disc directly?
Many conventional spine treatments focus on reducing inflammation or interrupting pain signals around the spine. Intradiscal regenerative treatment is fundamentally different because it targets the disc that may be contributing to the pain: identify the painful disc, precisely access it, and deliver regenerative therapy directly into it.
Rather than simply treating the area where pain is felt, the goal is to address the specific spinal structure believed to be contributing to your symptoms.
This makes accurate diagnosis and careful patient selection especially important.
Who may be a candidate?
Intradiscal PRP or stem cell-based therapy is not appropriate for every patient with back or neck pain. It may be considered for carefully selected patients with discogenic pain or certain degenerative disc conditions, particularly when imaging, symptoms, and clinical evaluation all indicate that one or more discs may be contributing. Dr. Shamloo considers:
Some discs may be too severely damaged or structurally compromised for regenerative treatment to be appropriate. The presence of degenerative disc disease on an MRI alone does not mean that an intradiscal injection is appropriate.
A minimally invasive approach to discogenic pain
Intradiscal regenerative treatment provides a highly targeted approach without requiring traditional spine surgery. For appropriately selected patients, potential advantages include:
These injections are not intended to promise that a severely damaged disc will simply grow back or become new again. The goal is to explore whether regenerative biologic treatment can improve the environment within an appropriately selected disc and potentially reduce pain and improve function.
An emerging frontier in regenerative spine medicine
Intradiscal regenerative therapy represents one of the more advanced and evolving applications of regenerative medicine. Research into intradiscal PRP and cell-based therapies continues to develop, with investigators studying their potential role in treating discogenic pain and degenerative disc disease.
Dr. Shamloo has incorporated these emerging approaches into his broader focus on advanced, minimally invasive spine treatments, offering carefully selected patients options beyond conventional injections and major spine surgery.
Because regenerative intradiscal therapies are an evolving area of medicine, results vary and treatment cannot guarantee restoration of a damaged disc or elimination of pain.